88
Maternal Risk Maternal Risk Factors Factors Fetal Assessment Fetal Assessment

Maternal Risk Factors Fetal Assessment

  • Upload
    magar

  • View
    53

  • Download
    0

Embed Size (px)

DESCRIPTION

Maternal Risk Factors Fetal Assessment. High Risk Pregnancy. The life or health of the mother or fetus is jeopardized Examples include: GDM Previous loss AMA HTN Abnormalities with the neonate. Perinatal Mortality. Overall maternal deaths are small Many deaths a preventable - PowerPoint PPT Presentation

Citation preview

Page 1: Maternal Risk Factors Fetal Assessment

Maternal Risk FactorsMaternal Risk FactorsFetal AssessmentFetal Assessment

Page 2: Maternal Risk Factors Fetal Assessment

High Risk PregnancyHigh Risk Pregnancy

The life or health of the mother or The life or health of the mother or fetus is jeopardizedfetus is jeopardized

Examples include:Examples include:– GDMGDM– Previous lossPrevious loss– AMAAMA– HTNHTN– Abnormalities with the neonateAbnormalities with the neonate

Page 3: Maternal Risk Factors Fetal Assessment

Perinatal MortalityPerinatal Mortality

Overall maternal deaths are smallOverall maternal deaths are small Many deaths a preventableMany deaths a preventable Education and prenatal care are veryEducation and prenatal care are very

importantimportant

Page 4: Maternal Risk Factors Fetal Assessment

Antepartum TestingAntepartum Testing FKCs BIDFKCs BID UTZUTZ

– FHRFHR– Gestation ageGestation age– AbnormalitiesAbnormalities– IUGRIUGR– Placental location and qualityPlacental location and quality– AFIAFI– PositionPosition– BPPBPP– Doppler flowDoppler flow– Fetal growthFetal growth

Page 5: Maternal Risk Factors Fetal Assessment

UltrasoundUltrasound

Can be done abdominally or Can be done abdominally or transvaginallytransvaginally

11stst trimester done to detect viability, trimester done to detect viability, calculate EDCcalculate EDC

22ndnd trimester done to detect trimester done to detect anomalies, calculate EDCanomalies, calculate EDC

33rdrd trimester done to do BPP, fetal trimester done to do BPP, fetal growth and well-being, AFIgrowth and well-being, AFI

Page 6: Maternal Risk Factors Fetal Assessment

Doppler Flow Analysis via Doppler Flow Analysis via UTZUTZ

Study blood blow in the fetus and Study blood blow in the fetus and placentaplacenta

Done on high risk mothers:Done on high risk mothers:– IUGRIUGR– HTNHTN– DMDM– Multiple gestationMultiple gestation

Page 7: Maternal Risk Factors Fetal Assessment

AFIAFI

Polyhydramnios – too much amniotic Polyhydramnios – too much amniotic fluidfluid

Oligohydramnios – too little amniotic Oligohydramnios – too little amniotic fluidfluid

Page 8: Maternal Risk Factors Fetal Assessment

Biophysical ProfileBiophysical Profile

Includes 5 components:Includes 5 components:– Fetal breathing movementsFetal breathing movements– Gross body movementsGross body movements– Fetal toneFetal tone– AFIAFI– NST - reactiveNST - reactive

Page 9: Maternal Risk Factors Fetal Assessment

AmniocentesisAmniocentesis

Used with direct ultrasoundUsed with direct ultrasound Less than 1% result in complicationsLess than 1% result in complications

– Complications include:Complications include: Fetal death, miscarriageFetal death, miscarriage Maternal hemorrhageMaternal hemorrhage Infection to fetusInfection to fetus Preterm laborPreterm labor Leakage of amniotic fluidLeakage of amniotic fluid

Page 10: Maternal Risk Factors Fetal Assessment

MeconiumMeconium

Visual inspection of amniotic fluidVisual inspection of amniotic fluid Meconium is defined as thin and Meconium is defined as thin and

thick and particulate thick and particulate Associated with fetal stress: hypoxia, Associated with fetal stress: hypoxia,

umbilical cord compressionumbilical cord compression

Page 11: Maternal Risk Factors Fetal Assessment

CVSCVS

Done between 9 -12 weeksDone between 9 -12 weeks Genetic studiesGenetic studies Removal of small amount of tissue Removal of small amount of tissue

from the fetal portion of the placentafrom the fetal portion of the placenta Complications: vaginal spotting, Complications: vaginal spotting,

miscarriage, ROM, chorioamnionitismiscarriage, ROM, chorioamnionitis If done prior to 10 weeks, increased If done prior to 10 weeks, increased

risk of limb anomaliesrisk of limb anomalies

Page 12: Maternal Risk Factors Fetal Assessment

AFPAFP

Genetic testGenetic test Done with mothers bloodDone with mothers blood 16-20 weeks gestation16-20 weeks gestation Mandated by state of CaliforniaMandated by state of California

Page 13: Maternal Risk Factors Fetal Assessment

EFMEFM

Third trimester goal is to continue to Third trimester goal is to continue to observe the fetus within the observe the fetus within the intrauterine environmentintrauterine environment

Goal: dx uteroplacental insufficiencyGoal: dx uteroplacental insufficiency NST vs. CSTNST vs. CST

Page 14: Maternal Risk Factors Fetal Assessment

NSTNST

90% of gross fetal body movements are 90% of gross fetal body movements are associated with accelerations of the associated with accelerations of the FHRFHR

Can be performed outpatientCan be performed outpatient Not as sensitiveNot as sensitive User friendly but must interpret stripUser friendly but must interpret strip Fetus may be in a sleep state or Fetus may be in a sleep state or

affected by maternal medications, affected by maternal medications, glucose etc.glucose etc.

Page 15: Maternal Risk Factors Fetal Assessment
Page 16: Maternal Risk Factors Fetal Assessment

NSTNST

To be reactive must meet criteriaTo be reactive must meet criteria Must be at least 20 minutes in lengthMust be at least 20 minutes in length Must have 2 or more accelerations Must have 2 or more accelerations

that meet the ’15 X 15’ criteriathat meet the ’15 X 15’ criteria Must have a normal baselineMust have a normal baseline Must have LTVMust have LTV

Page 17: Maternal Risk Factors Fetal Assessment

NSTNST

To stimulate a fetus that is not To stimulate a fetus that is not meeting criteria:meeting criteria:– Change positions of the mother – LS, RSChange positions of the mother – LS, RS– Increase fluidsIncrease fluids– Acoustic stimulatorAcoustic stimulator

Page 18: Maternal Risk Factors Fetal Assessment

CSTCST

Done in the inpatient setting only!Done in the inpatient setting only! Has contraindicationsHas contraindications May be expensive if meds/IV neededMay be expensive if meds/IV needed Monitored for 10 minutes first Monitored for 10 minutes first Then may use nipple stimulation or Then may use nipple stimulation or

oxytocin stimulationoxytocin stimulation No late decelerations than negative No late decelerations than negative

CSTCST

Page 19: Maternal Risk Factors Fetal Assessment

CSTCST

Page 20: Maternal Risk Factors Fetal Assessment
Page 21: Maternal Risk Factors Fetal Assessment

Endocrine and Metabolic Endocrine and Metabolic DisordersDisorders

#1 Diabetes Mellitus#1 Diabetes Mellitus Disorders of the thyroidDisorders of the thyroid HyperemesisHyperemesis

Page 22: Maternal Risk Factors Fetal Assessment

DiabetesDiabetes

HyperglycemiaHyperglycemia May be due to inadequate insulin May be due to inadequate insulin

action or due to impaired insulin action or due to impaired insulin secretionsecretion

Type 1 – insulin deficiencyType 1 – insulin deficiency Type 2 – insulin resistanceType 2 – insulin resistance GDM – glucose intolerance during GDM – glucose intolerance during

pregnancypregnancy

Page 23: Maternal Risk Factors Fetal Assessment

DMDM

1010thth week fetus produces it own insulin week fetus produces it own insulin Insulin does not cross the placental Insulin does not cross the placental

barrierbarrier Glucose levels in the fetus and directly Glucose levels in the fetus and directly

proportional to the motherproportional to the mother 22ndnd and 3 and 3rdrd trimesters – decreased trimesters – decreased

tolerance to glucose, increased insulin tolerance to glucose, increased insulin resistance, increased hepatic function resistance, increased hepatic function of glucoseof glucose

Page 24: Maternal Risk Factors Fetal Assessment

Diabetic NephropathyDiabetic Nephropathy

Increased risks for:Increased risks for:– PreeclampsiaPreeclampsia– IUGRIUGR– PTLPTL– Fetal distressFetal distress– IUFDIUFD– Neonatal deathNeonatal death

Page 25: Maternal Risk Factors Fetal Assessment

DMDM

Poor glycemic control is associated Poor glycemic control is associated with increased risks of miscarriage at with increased risks of miscarriage at time of conceptiontime of conception

Poor glycemic control in later part of Poor glycemic control in later part of pregnancy is assoc. with fetal pregnancy is assoc. with fetal macrosomia and polyhydramniosmacrosomia and polyhydramnios

Page 26: Maternal Risk Factors Fetal Assessment

PolyhydramniosPolyhydramnios

May compress on the vena cava and May compress on the vena cava and aorta causing hypotension, PROM, PP aorta causing hypotension, PROM, PP hemorrhage, maternal dyspneahemorrhage, maternal dyspnea

Page 27: Maternal Risk Factors Fetal Assessment

MacrosomiaMacrosomia

Disproportionate increase in shoulder Disproportionate increase in shoulder and trunk sizeand trunk size

4000-4500gms or greater4000-4500gms or greater Fetus will have excess stores of Fetus will have excess stores of

glycogenglycogen Increased risks ofIncreased risks of

– Shoulder dystociaShoulder dystocia– C/SC/S– Assisted deliveriesAssisted deliveries

Page 28: Maternal Risk Factors Fetal Assessment

IUGRIUGR

Compromised uteroplacental Compromised uteroplacental insufficiencyinsufficiency

02 available to the fetus is decreased02 available to the fetus is decreased

Page 29: Maternal Risk Factors Fetal Assessment

RDSRDS

Increased RDS due to high glucose Increased RDS due to high glucose levelslevels

Delays pulmonary maturityDelays pulmonary maturity

Page 30: Maternal Risk Factors Fetal Assessment

Neonatal HypoglycemiaNeonatal Hypoglycemia

Usually 30-60 minutes after birthUsually 30-60 minutes after birth Due to high glucose levels during Due to high glucose levels during

pregnancy and rapid use of glucose pregnancy and rapid use of glucose after birthafter birth

Related to mothers level of glucose Related to mothers level of glucose controlcontrol

Page 31: Maternal Risk Factors Fetal Assessment

Labs with DMLabs with DM

HBA1cHBA1c 1 hour PP1 hour PP FBSFBS

Page 32: Maternal Risk Factors Fetal Assessment

DietDiet

Sweet success dietSweet success diet Well balanced dietWell balanced diet 6 small meals / day6 small meals / day Have snack at HSHave snack at HS Never skip mealsNever skip meals Avoid simple sugarsAvoid simple sugars

Page 33: Maternal Risk Factors Fetal Assessment

InsulinInsulin

Regular/Lispro and NPHRegular/Lispro and NPH 2/3 dose in am and 1/3 dose in pm2/3 dose in am and 1/3 dose in pm

Page 34: Maternal Risk Factors Fetal Assessment

Monitoring Glucose LevelsMonitoring Glucose Levels

FBSFBS 1 hour PP1 hour PP HSHS 5 checks / day5 checks / day

Page 35: Maternal Risk Factors Fetal Assessment

Fetal SurveillanceFetal Surveillance

NSTs done around 26 weeks, weeklyNSTs done around 26 weeks, weekly

At 32 weeks done biweekly with At 32 weeks done biweekly with NST/BPPNST/BPP

Page 36: Maternal Risk Factors Fetal Assessment

Infections and DMInfections and DM

Infections are increased:Infections are increased:– CandidiasisCandidiasis– UTIsUTIs– PP infectionsPP infections

Page 37: Maternal Risk Factors Fetal Assessment

DMDM

Increased risk of IUFD after 36 weeksIncreased risk of IUFD after 36 weeks Increased congenital anomaliesIncreased congenital anomalies

– Cardiac defectsCardiac defects– CNS defectsCNS defects

Spina bifidaSpina bifida anencephalyanencephaly

– Skeletal defectsSkeletal defects

Page 38: Maternal Risk Factors Fetal Assessment

DM and laborDM and labor

Continuous fetal monitoringContinuous fetal monitoring Blood glucose levels in tight controlBlood glucose levels in tight control Be prepared for CPDBe prepared for CPD

Page 39: Maternal Risk Factors Fetal Assessment

GDMGDM

Women with GDM at risk of Women with GDM at risk of developing DM later on in lifedeveloping DM later on in life

NSTs around 28 weeksNSTs around 28 weeks

Page 40: Maternal Risk Factors Fetal Assessment

HyperthyroidismHyperthyroidism

Typically caused by Grave’s diseaseTypically caused by Grave’s disease S/S: S/S:

– FatigueFatigue– Heat intoleranceHeat intolerance– Warm skinWarm skin– DiaphoresisDiaphoresis– Weight lossWeight loss

Page 41: Maternal Risk Factors Fetal Assessment

Should be treated in pregnancyShould be treated in pregnancy Tx with PTUTx with PTU Beta blockersBeta blockers May lead to thyroid storm if May lead to thyroid storm if

untreateduntreated

Page 42: Maternal Risk Factors Fetal Assessment

HypothyroidismHypothyroidism

Usually caused by Hashimoto’sUsually caused by Hashimoto’s S/S:S/S:

– Weight gainWeight gain– Cold intoleranceCold intolerance– FatigueFatigue– Hair lossHair loss– ConstipationConstipation– Dry skinDry skin

Page 43: Maternal Risk Factors Fetal Assessment

Tx with thyroid hormones such as Tx with thyroid hormones such as synthroid or levothyroxinesynthroid or levothyroxine

Maintain TSH wnlMaintain TSH wnl Checked periodically throughout the Checked periodically throughout the

pregnancypregnancy

Page 44: Maternal Risk Factors Fetal Assessment

Cardiovascular DisordersCardiovascular Disorders

The heart must compensate for the The heart must compensate for the increased workloadincreased workload

If the cardiac changes are not well If the cardiac changes are not well tolerated than cardiac failure can tolerated than cardiac failure can developdevelop

1% of pregnancies are complicated 1% of pregnancies are complicated by heart diseaseby heart disease

Page 45: Maternal Risk Factors Fetal Assessment

NY Heart Association NY Heart Association ClassesClasses

Class IClass I Class IIClass II Class IIIClass III Class IVClass IV

Page 46: Maternal Risk Factors Fetal Assessment

Cardiac output is increased Cardiac output is increased Peak of the increase 20-24 weeks Peak of the increase 20-24 weeks

gestationgestation Cardiac problems should be Cardiac problems should be

managed with cardiologistmanaged with cardiologist Mortality with pulmonary Mortality with pulmonary

hypertension and pregnancy is more hypertension and pregnancy is more than 50%than 50%

Diet: low sodiumDiet: low sodium

Page 47: Maternal Risk Factors Fetal Assessment

Nursing CareNursing Care

Avoiding anemiaAvoiding anemia Avoid strenuous activityAvoid strenuous activity Monitor for: cardiac failure and Monitor for: cardiac failure and

pulmonary congestionpulmonary congestion

Page 48: Maternal Risk Factors Fetal Assessment

During LaborDuring Labor

Side lying positionSide lying position Prophylactic antibioticProphylactic antibiotic EpiduralEpidural Attempt vaginal deliveryAttempt vaginal delivery If anticoagulant therapy is needed:If anticoagulant therapy is needed:

– Heparin Heparin – LovenoxLovenox

Page 49: Maternal Risk Factors Fetal Assessment

MVPMVP

Common and usually benignCommon and usually benign May experience syncope, palpitations May experience syncope, palpitations

and dyspneaand dyspnea Prophylactic antibiotics given before Prophylactic antibiotics given before

invasive procedure or birthinvasive procedure or birth

Page 50: Maternal Risk Factors Fetal Assessment

AnemiaAnemia

Most common iron deficiencyMost common iron deficiency Hgb falls below 12 (most labs)Hgb falls below 12 (most labs) Typically seen in the end of 2Typically seen in the end of 2ndnd

trimestertrimester Iron supplementationIron supplementation

Page 51: Maternal Risk Factors Fetal Assessment

Folic Acid Deficiency Folic Acid Deficiency AnemiaAnemia

Increases risk of NTD, cleft lipIncreases risk of NTD, cleft lip Recommended dose 400 mcg/dayRecommended dose 400 mcg/day Supplemented in cereal and many Supplemented in cereal and many

other foodsother foods

Page 52: Maternal Risk Factors Fetal Assessment

Sickle Cell AnemiaSickle Cell Anemia

Abnormal hemoglobin SS types in the Abnormal hemoglobin SS types in the bloodblood

People have recurrent attacks of People have recurrent attacks of fever and pain in the abdomen and fever and pain in the abdomen and extremitiesextremities

Caused from tissue hypoxia, edemaCaused from tissue hypoxia, edema African-AmericansAfrican-Americans

Page 53: Maternal Risk Factors Fetal Assessment

Sickle Cell TraitSickle Cell Trait

Typically asymptomaticTypically asymptomatic Sickling of the RBCs but with a Sickling of the RBCs but with a

normal RBC life spannormal RBC life span

Page 54: Maternal Risk Factors Fetal Assessment

ThalassemiaThalassemia

Common anemiaCommon anemia Insufficient amount of Hgb is Insufficient amount of Hgb is

produced to fill the RBCsproduced to fill the RBCs Mediterranean regionMediterranean region Genetic disorderGenetic disorder May be associated with LBW babies May be associated with LBW babies

and increased fetal deathand increased fetal death

Page 55: Maternal Risk Factors Fetal Assessment

AsthmaAsthma

Common with FHCommon with FH 1-4% of pregnant women have Asthma1-4% of pregnant women have Asthma Possible adverse events associated Possible adverse events associated

with asthma:with asthma:– LBWLBW– Perinatal mortalityPerinatal mortality– PreeclampsiaPreeclampsia– Complicated laborComplicated labor– HyperemesisHyperemesis

Page 56: Maternal Risk Factors Fetal Assessment

Asthma ContinuedAsthma Continued

Goal is to relieve the attack, prevent Goal is to relieve the attack, prevent the asthma attack, and maintain 02the asthma attack, and maintain 02

Should be managed with OB and ENTShould be managed with OB and ENT May require tx: albuterol, steroids, May require tx: albuterol, steroids,

O2O2

Page 57: Maternal Risk Factors Fetal Assessment

EpilepsyEpilepsy

Seizure disorderSeizure disorder May result from developmental May result from developmental

abnormalities or injuryabnormalities or injury 20% have an increase in seizure 20% have an increase in seizure

activity during pregnancyactivity during pregnancy Risks: more seizures, risk of vaginal Risks: more seizures, risk of vaginal

bleeding, abruptio placentae, fetus bleeding, abruptio placentae, fetus may experience seizuresmay experience seizures

Page 58: Maternal Risk Factors Fetal Assessment

Epilepsy ContinuedEpilepsy Continued

Use of antiepeleptic meds during Use of antiepeleptic meds during pregnancy has been linked to risks pregnancy has been linked to risks for the fetusfor the fetus

Smallest therapeutic dose to be Smallest therapeutic dose to be givengiven

Daily folic acid supplementationDaily folic acid supplementation Managed with OB and neurologistManaged with OB and neurologist

Page 59: Maternal Risk Factors Fetal Assessment

RARA

Chronic arthritisChronic arthritis Pain upon movement and swelling in Pain upon movement and swelling in

joint spacesjoint spaces More often in womenMore often in women 2/3 of women with RA find the 2/3 of women with RA find the

severity of symptoms decrease severity of symptoms decrease during pregnancyduring pregnancy

Typically give baby ASATypically give baby ASA

Page 60: Maternal Risk Factors Fetal Assessment

SLESLE

Inflammatory disease, autoimmune Inflammatory disease, autoimmune antibody productionantibody production

Advised to wait until in remission for Advised to wait until in remission for 6 months to become pregnant6 months to become pregnant

15-60% of women will develop 15-60% of women will develop exacerbation of SLE during exacerbation of SLE during pregnancy or postpartumpregnancy or postpartum

Tx: ASA and steroidsTx: ASA and steroids

Page 61: Maternal Risk Factors Fetal Assessment

CholelithiasisCholelithiasis

More often in womenMore often in women Pregnancy makes women more Pregnancy makes women more

vulnerablevulnerable Surgery often delayed until after Surgery often delayed until after

deliverydelivery

Page 62: Maternal Risk Factors Fetal Assessment

AppendicitisAppendicitis

Dx may take more time to findDx may take more time to find Sxs: abdominal pain, nausea, Sxs: abdominal pain, nausea,

vomiting, loss of appetitevomiting, loss of appetite Increases incidence of PTL or SABIncreases incidence of PTL or SAB

Page 63: Maternal Risk Factors Fetal Assessment

Maternal InfectionsMaternal Infections

Page 64: Maternal Risk Factors Fetal Assessment

TORCHTORCH

Toxoplasmosis – protozoan infection, Toxoplasmosis – protozoan infection, neonatal effects – jaundice, neonatal effects – jaundice, hydrocephalus, microcephalyhydrocephalus, microcephaly

Other- Heb A or B, Group B, Varicella, Other- Heb A or B, Group B, Varicella, HIVHIV

Rubella (German measles) – if Rubella (German measles) – if contracted in 1contracted in 1stst Trimester fetus may Trimester fetus may have congenital deformitieshave congenital deformities

Page 65: Maternal Risk Factors Fetal Assessment

TORCHTORCH

CMV- transmitted person to person, CMV- transmitted person to person, may cause CNS damage to fetusmay cause CNS damage to fetus

Herpes Simplex (HSV 2) – if initial Herpes Simplex (HSV 2) – if initial infection occurs in pregnancy, higher infection occurs in pregnancy, higher incidence of perinatal loss. Fetus incidence of perinatal loss. Fetus may pick up virus if present in the may pick up virus if present in the vagina during laborvagina during labor

Page 66: Maternal Risk Factors Fetal Assessment

Mental Health Mental Health DisordersDisorders

Page 67: Maternal Risk Factors Fetal Assessment

Anxiety DisordersAnxiety Disorders

Most common mental disordersMost common mental disorders Include: phobias, panic disorders, Include: phobias, panic disorders,

OCD, PTSDOCD, PTSD Tx: relaxation techniques, breathing Tx: relaxation techniques, breathing

exercises, imageryexercises, imagery

Page 68: Maternal Risk Factors Fetal Assessment

Depression in PregnancyDepression in Pregnancy

6% of women develop depression for 6% of women develop depression for the 1the 1stst time during pregnancy time during pregnancy

Tx: counseling and tx with SSRIsTx: counseling and tx with SSRIs Wellbutrin only med named as Wellbutrin only med named as

Category BCategory B Many women opt to DC meds during Many women opt to DC meds during

pregnancypregnancy

Page 69: Maternal Risk Factors Fetal Assessment

Substance Abuse in Substance Abuse in PregnancyPregnancy

Page 70: Maternal Risk Factors Fetal Assessment

Substance AbuseSubstance Abuse

Damaging effects well documented in Damaging effects well documented in research to fetusresearch to fetus

Any use of ETOH or illicit drugs during Any use of ETOH or illicit drugs during pregnancy is considered abusepregnancy is considered abuse

31% of women had used one or more 31% of women had used one or more substances during pregnancy (as substances during pregnancy (as compared to 62% during compared to 62% during prepregnancy)prepregnancy)

Page 71: Maternal Risk Factors Fetal Assessment

SmokingSmoking

Risks of any amount of smoking Risks of any amount of smoking include:include:– SABSAB– SGASGA– BleedingBleeding– IUFDIUFD– PrematurityPrematurity– SIDSSIDS

Page 72: Maternal Risk Factors Fetal Assessment

AlcoholAlcohol

Many women reluctant to tell health Many women reluctant to tell health care providercare provider

Risks:Risks:– LBWLBW– Mental retardationMental retardation– Learning and physical deficitsLearning and physical deficits– With FAS – severe facial deformitiesWith FAS – severe facial deformities

Page 73: Maternal Risk Factors Fetal Assessment

Alcohol during PregnancyAlcohol during Pregnancy

Risks to mother:Risks to mother:– HTNHTN– AnemiaAnemia– Nutritional deficitsNutritional deficits– PancreatitisPancreatitis– CirrhosisCirrhosis– Alcoholic hepatitisAlcoholic hepatitis

Page 74: Maternal Risk Factors Fetal Assessment

MarijuanaMarijuana

Crosses the placenta and causes Crosses the placenta and causes increased carbon monoxide levels in increased carbon monoxide levels in mother’s bloodmother’s blood

May cause fetal abnormalitiesMay cause fetal abnormalities

Page 75: Maternal Risk Factors Fetal Assessment

CocaineCocaine

In the US, 10-15% of all pregnant In the US, 10-15% of all pregnant women use cocainewomen use cocaine

Problems associated with use: Problems associated with use: polydrug use, poor health, poor polydrug use, poor health, poor nutrition, STIs, infections, HIVnutrition, STIs, infections, HIV

Poverty big issuePoverty big issue

Page 76: Maternal Risk Factors Fetal Assessment

Cocaine in PregnancyCocaine in Pregnancy

Maternal effects:Maternal effects:– Cardiovascular Cardiovascular

stressstress– TachycardiaTachycardia– HTNHTN– DysrhythmiasDysrhythmias– MIMI– Liver damageLiver damage– SzSz– Pulmonary diseasePulmonary disease– DeathDeath

Fetal Fetal Complications:Complications:– Abruptio placentaeAbruptio placentae– PTLPTL– Precipitous laborPrecipitous labor– Risks for abdominal Risks for abdominal

pregnancypregnancy– Fetal complications Fetal complications

after deliveryafter delivery

Page 77: Maternal Risk Factors Fetal Assessment

Opiates in PregnancyOpiates in Pregnancy

Drugs include: heroin, Demerol, Drugs include: heroin, Demerol, morphine, codeine, methadonemorphine, codeine, methadone

Methadone is used to treat addiction Methadone is used to treat addiction to other opiatesto other opiates

Possible effects on pregnancy and Possible effects on pregnancy and heroin use are: Preeclampsia, PROM, heroin use are: Preeclampsia, PROM, infections, PTLinfections, PTL

Tx: Methadone and psychotherapyTx: Methadone and psychotherapy Goal: prevent withdrawal symptomsGoal: prevent withdrawal symptoms

Page 78: Maternal Risk Factors Fetal Assessment

MethamphetamineMethamphetamine

CNS stimulantCNS stimulant Most common use n the 18-30 yr old Most common use n the 18-30 yr old

rangerange Neonatal complications include:Neonatal complications include:

– IUGRIUGR– PRL/PTBPRL/PTB

Page 79: Maternal Risk Factors Fetal Assessment

Postpartum Postpartum Psychologic Psychologic

ComplicationsComplications

Page 80: Maternal Risk Factors Fetal Assessment

Baby BluesBaby Blues

Usually within 4 weeks of childbirthUsually within 4 weeks of childbirth Many experience thisMany experience this

Page 81: Maternal Risk Factors Fetal Assessment

PPDPPD

Intense sadness, crying all the time, Intense sadness, crying all the time, mood swings, fears, anger, anxiety, mood swings, fears, anger, anxiety, irritabilityirritability

Incidence of PPD at 8 weeks – 12% Incidence of PPD at 8 weeks – 12% and 8% at 12 weeksand 8% at 12 weeks

Many women feel guiltyMany women feel guilty May need tx but usually resolves on May need tx but usually resolves on

ownown

Page 82: Maternal Risk Factors Fetal Assessment

Postpartum PsychosisPostpartum Psychosis

Delusions, hurting self or the infant, Delusions, hurting self or the infant, emotional lability, insomnia, emotional lability, insomnia, suspiciousness, confusion, obsessive suspiciousness, confusion, obsessive concerns regarding the babyconcerns regarding the baby

1-2/1000 births1-2/1000 births 35-60% recurrence with each 35-60% recurrence with each

subsequent birthsubsequent birth Usually symptoms appear within 8 Usually symptoms appear within 8

weeks of birthweeks of birth

Page 83: Maternal Risk Factors Fetal Assessment

Medical ManagementMedical Management

Supportive familySupportive family Intense psychotherapyIntense psychotherapy EmergencyEmergency Tx: SSRIsTx: SSRIs SSRIs contraindicated while SSRIs contraindicated while

breastfeedingbreastfeeding

Page 84: Maternal Risk Factors Fetal Assessment

1. A client asks the nurse to again 1. A client asks the nurse to again explain the purpose of the explain the purpose of the amniocentesis test. The nurse amniocentesis test. The nurse responds that one purpose of this test responds that one purpose of this test is to indicate the:is to indicate the:– A. Accurate age of the fetusA. Accurate age of the fetus– B. Presence of certain congenital B. Presence of certain congenital

anomaliesanomalies– C. Biparietal diameter of the skullC. Biparietal diameter of the skull– D. Hormone content of the amniotic fluidD. Hormone content of the amniotic fluid– E. Mainly the presence of Down’s E. Mainly the presence of Down’s

syndrome syndrome

Page 85: Maternal Risk Factors Fetal Assessment

2. The nurse explains to a new 2. The nurse explains to a new mother that the condition of SGA is mother that the condition of SGA is caused by:caused by:– A. Placental insufficiencyA. Placental insufficiency– B. Maternal obesityB. Maternal obesity– C. PrimiparaC. Primipara– D. Genetic predispositionD. Genetic predisposition

Page 86: Maternal Risk Factors Fetal Assessment

3. A pregnant client with diabetes is 3. A pregnant client with diabetes is controlled by insulin. When she asks the controlled by insulin. When she asks the nurse what will happen to her insulin nurse what will happen to her insulin requirements during pregnancy, the correct requirements during pregnancy, the correct response is:response is:– A. “Because your case is so mild, you are likely A. “Because your case is so mild, you are likely

not to need much insulin during your not to need much insulin during your pregnancy”pregnancy”

– B. “It’s likely that as the pregnancy progresses B. “It’s likely that as the pregnancy progresses you will need increased insulin”you will need increased insulin”

– C. “Every case is individual so there is really no C. “Every case is individual so there is really no way to know”way to know”

– D. “If you follow the diet closely and don’t gain D. “If you follow the diet closely and don’t gain too much weight, your insulin needs should stay too much weight, your insulin needs should stay the same”the same”

Page 87: Maternal Risk Factors Fetal Assessment

4. The nurse in the newborn nursery 4. The nurse in the newborn nursery understands that assessing a understands that assessing a newborn with a diabetic mother, newborn with a diabetic mother, initially the insulin level would be:initially the insulin level would be:– A. Higher than in normal infantsA. Higher than in normal infants– B. Lower than in normal infantsB. Lower than in normal infants– C. The same as in normal infantsC. The same as in normal infants– D. Varied from baby to babyD. Varied from baby to baby

Page 88: Maternal Risk Factors Fetal Assessment

5. A client is admitted to L&D, at 38 5. A client is admitted to L&D, at 38 weeks gestation. She is there for weeks gestation. She is there for evaluation because she is evaluation because she is experiencing polyhydramnios. The experiencing polyhydramnios. The nurse understands that this diagnosis nurse understands that this diagnosis means that:means that:– A. There is the normal amount of A. There is the normal amount of

amniotic fluid, thinner in volumeamniotic fluid, thinner in volume– B. A less-than-normal amount of amniotic B. A less-than-normal amount of amniotic

fluid is presentfluid is present– C. An excessive amount of amniotic fluid C. An excessive amount of amniotic fluid

is presentis present– D. A leak is causing the fluid to D. A leak is causing the fluid to

accumulate outside the amniotic sacaccumulate outside the amniotic sac